347 related articles for article (PubMed ID: 6321949)
41. In vitro regulation of ornithine decarboxylase in dog thyroid slices.
Mockel J; Decaux G; Unger J; Dumont JE
Endocrinology; 1980 Dec; 107(6):2069-75. PubMed ID: 6159206
[TBL] [Abstract][Full Text] [Related]
42. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
Rose RJ; Liu H; Palmer D; Maurice DH
Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
[TBL] [Abstract][Full Text] [Related]
43. OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells.
Shimizu E; Kobayashi Y; Oki Y; Kawasaki T; Yoshimi T; Nakamura H
Life Sci; 1999; 64(23):2081-8. PubMed ID: 10372650
[TBL] [Abstract][Full Text] [Related]
44. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.
Endoh M; Yamashita S; Taira N
J Pharmacol Exp Ther; 1982 Jun; 221(3):775-83. PubMed ID: 6283063
[TBL] [Abstract][Full Text] [Related]
45. Differential inhibition of calmodulin-sensitive phosphodiesterase and Ca++-adenosine triphosphatase by chlorpromazine-linked calmodulin.
Prozialeck WC; Wallace TL; Weiss B
J Pharmacol Exp Ther; 1987 Oct; 243(1):171-9. PubMed ID: 2822896
[TBL] [Abstract][Full Text] [Related]
46. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
Barnette MS; Manning CD; Price WJ; Barone FC
J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736
[TBL] [Abstract][Full Text] [Related]
47. Desensitization of carbamylcholine-mediated cyclic GMP accumulation in dog thyroid slices.
Decoster C; Moreau C; Dumont JE
Biochim Biophys Acta; 1984 Apr; 798(2):235-9. PubMed ID: 6324877
[TBL] [Abstract][Full Text] [Related]
48. In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity.
Nagata K; Ogawa T; Omosu M; Fujimoto K; Hayashi S
Arzneimittelforschung; 1985; 35(7):1034-6. PubMed ID: 2996562
[TBL] [Abstract][Full Text] [Related]
49. Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity.
Nagasaka A; Hidaka H
Biochim Biophys Acta; 1976 Jul; 438(2):449-60. PubMed ID: 182233
[TBL] [Abstract][Full Text] [Related]
50. Sensitivity of Ca-dependent slow action potentials to methacholine is induced by phosphodiesterase inhibitors in embryonic chick ventricles.
Linden J; Vogel S; Sperelakis N
J Pharmacol Exp Ther; 1982 Aug; 222(2):383-8. PubMed ID: 6178816
[TBL] [Abstract][Full Text] [Related]
51. 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain.
Schwabe U; Miyake M; Ohga Y; Daly JW
Mol Pharmacol; 1976 Nov; 12(6):900-10. PubMed ID: 187926
[No Abstract] [Full Text] [Related]
52. Modulation of cyclic AMP action in the dog thyroid by its agonist and antagonist Sp- and Rp-adenosine 3',5'-monophosphorothioate.
Erneux C; Van Sande J; Jastorff B; Dumont JE
Biochem J; 1986 Feb; 234(1):193-7. PubMed ID: 3010952
[TBL] [Abstract][Full Text] [Related]
53. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
Alvarez R; Banerjee GL; Bruno JJ; Jones GL; Littschwager K; Strosberg AM; Venuti MC
Mol Pharmacol; 1986 Jun; 29(6):554-60. PubMed ID: 3012320
[TBL] [Abstract][Full Text] [Related]
54. Opiates, cyclic nucleotides, and xanthines.
Collier HO; Francis DL; Roy AC
Adv Biochem Psychopharmacol; 1976; 15():337-45. PubMed ID: 192053
[TBL] [Abstract][Full Text] [Related]
55. Muscarinic antagonism of the effects of phosphodiesterase inhibitor (methylisobutylxanthine) in embryonic chick ventricle.
Biegon RL; Epstein PM; Pappano AJ
J Pharmacol Exp Ther; 1980 Nov; 215(2):348-56. PubMed ID: 6160237
[TBL] [Abstract][Full Text] [Related]
56. 3':5'-cyclic-nucleotide phosphodiesterases of mammalian sera.
Asano T; Hidaka H
Biochim Biophys Acta; 1975 Jul; 397(1):124-33. PubMed ID: 238629
[TBL] [Abstract][Full Text] [Related]
57. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries.
Birk S; Edvinsson L; Olesen J; Kruuse C
Eur J Pharmacol; 2004 Apr; 489(1-2):93-100. PubMed ID: 15063160
[TBL] [Abstract][Full Text] [Related]
58. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
Ahluwalia GS; Rhoads AR
Biochem Pharmacol; 1982 Mar; 31(5):665-9. PubMed ID: 6177320
[TBL] [Abstract][Full Text] [Related]
59. Tumor promoters as probes of protein kinase C in dog thyroid cell: inhibition of the primary effects of carbamylocholine and reproduction of some distal effects.
Mockel J; Van Sande J; Decoster C; Dumont JE
Metabolism; 1987 Feb; 36(2):137-43. PubMed ID: 3027498
[TBL] [Abstract][Full Text] [Related]
60. The role of calcium and guanosine 3':5'-monophosphate in the action of acetylcholine on thyroid metabolism.
Decoster C; Mockel J; Van Sande J; Unger J; Dumont JE
Eur J Biochem; 1980 Feb; 104(1):199-208. PubMed ID: 6245867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
